GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (TSE:2395) » Definitions » Net Margin %

Shin Nippon Biomedical Laboratories (TSE:2395) Net Margin % : 13.58% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Shin Nippon Biomedical Laboratories's Net Income for the three months ended in Dec. 2023 was 円828 Mil. Shin Nippon Biomedical Laboratories's Revenue for the three months ended in Dec. 2023 was 円6,101 Mil. Therefore, Shin Nippon Biomedical Laboratories's net margin for the quarter that ended in Dec. 2023 was 13.58%.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's Net Margin % or its related term are showing as below:

TSE:2395' s Net Margin % Range Over the Past 10 Years
Min: -21.42   Med: 17.73   Max: 40.16
Current: 20.91


TSE:2395's Net Margin % is ranked better than
93.67% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.37 vs TSE:2395: 20.91

Shin Nippon Biomedical Laboratories Net Margin % Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Net Margin % Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.52 24.23 40.16 24.15 20.91

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.59 23.66 26.20 13.58 20.51

Competitive Comparison of Shin Nippon Biomedical Laboratories's Net Margin %

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Net Margin % falls into.



Shin Nippon Biomedical Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Shin Nippon Biomedical Laboratories's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=5531.261/26450.468
=20.91 %

Shin Nippon Biomedical Laboratories's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=828.478/6100.678
=13.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shin Nippon Biomedical Laboratories  (TSE:2395) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Shin Nippon Biomedical Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (TSE:2395) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (TSE:2395) Headlines

No Headlines